Steven Kelly, Founder of Carisma Therapeutics

Steven Kelly is the founder of Carisma Therapeutics. Carisma Therapeutics has raised $120M in total funding. Latest round: Series B.

About Steven Kelly

Steven Kelly is the CEO of Carisma Therapeutics, a clinical-stage biopharmaceutical company focused on developing a cell therapy platform for hard-to-treat cancers. He oversees Phase I oncology clinical trials and led the company after its first patient was dosed with CT-0508, a CAR-M therapy.

Steven Kelly at a glance

More founders in Philadelphia, PA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library